2167 related articles for article (PubMed ID: 30333180)
1. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
[TBL] [Abstract][Full Text] [Related]
2. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
[TBL] [Abstract][Full Text] [Related]
3. Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice.
Yamazaki K; Kato T; Tsuboi Y; Miyauchi E; Suda W; Sato K; Nakajima M; Yokoji-Takeuchi M; Yamada-Hara M; Tsuzuno T; Matsugishi A; Takahashi N; Tabeta K; Miura N; Okuda S; Kikuchi J; Ohno H; Yamazaki K
Front Immunol; 2021; 12():766170. PubMed ID: 34707622
[TBL] [Abstract][Full Text] [Related]
4. Correlation Analysis of Gut Microbiota and Serum Metabolome With
Dong Z; Lv W; Zhang C; Chen S
Front Cell Infect Microbiol; 2022; 12():858902. PubMed ID: 35463645
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota.
Watanabe K; Katagiri S; Takahashi H; Sasaki N; Maekawa S; Komazaki R; Hatasa M; Kitajima Y; Maruyama Y; Shiba T; Komatsu K; Ohsugi Y; Tanaka K; Matsuzawa A; Hirota T; Tohara H; Eguchi Y; Anzai K; Hattori A; Iwata T
FASEB J; 2021 Feb; 35(2):e21171. PubMed ID: 33197074
[TBL] [Abstract][Full Text] [Related]
6. Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice.
Ohtsu A; Takeuchi Y; Katagiri S; Suda W; Maekawa S; Shiba T; Komazaki R; Udagawa S; Sasaki N; Hattori M; Izumi Y
Oral Dis; 2019 Apr; 25(3):868-880. PubMed ID: 30667148
[TBL] [Abstract][Full Text] [Related]
7. Brazilian propolis mitigates impaired glucose and lipid metabolism in experimental periodontitis in mice.
Nakajima M; Arimatsu K; Minagawa T; Matsuda Y; Sato K; Takahashi N; Nakajima T; Yamazaki K
BMC Complement Altern Med; 2016 Aug; 16(1):329. PubMed ID: 27576340
[TBL] [Abstract][Full Text] [Related]
8. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system.
Sato K; Takahashi N; Kato T; Matsuda Y; Yokoji M; Yamada M; Nakajima T; Kondo N; Endo N; Yamamoto R; Noiri Y; Ohno H; Yamazaki K
Sci Rep; 2017 Jul; 7(1):6955. PubMed ID: 28761156
[TBL] [Abstract][Full Text] [Related]
9. Orally administered pathobionts and commensals have comparable and innocuous systemic effects on germ-free mice.
Yamazaki K; Sato K; Tsuzuno T; Sulijaya B; Mashima I; Kawamura Y; Yamazaki K
Microb Pathog; 2020 Mar; 140():103962. PubMed ID: 31904448
[TBL] [Abstract][Full Text] [Related]
10. Oral infection with a periodontal pathogen alters oral and gut microbiomes.
Simas AM; Kramer CD; Weinberg EO; Genco CA
Anaerobe; 2021 Oct; 71():102399. PubMed ID: 34090994
[TBL] [Abstract][Full Text] [Related]
11. Gut flora alterations due to lipopolysaccharide derived from Porphyromonas gingivalis.
Sugiyama N; Uehara O; Morikawa T; Paudel D; Ebata K; Hiraki D; Harada F; Yoshida K; Kato S; Nagasawa T; Miura H; Abiko Y; Furuichi Y
Odontology; 2022 Oct; 110(4):673-681. PubMed ID: 35333990
[TBL] [Abstract][Full Text] [Related]
12. Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4
Sohn J; Li L; Zhang L; Settem RP; Honma K; Sharma A; Falkner KL; Novak JM; Sun Y; Kirkwood KL
Mol Oral Microbiol; 2022 Apr; 37(2):42-52. PubMed ID: 34958712
[TBL] [Abstract][Full Text] [Related]
13. Ligature-induced periodontitis in mice induces elevated levels of circulating interleukin-6 but shows only weak effects on adipose and liver tissues.
Matsuda Y; Kato T; Takahashi N; Nakajima M; Arimatsu K; Minagawa T; Sato K; Ohno H; Yamazaki K
J Periodontal Res; 2016 Oct; 51(5):639-46. PubMed ID: 26667667
[TBL] [Abstract][Full Text] [Related]
14. Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model.
Kashiwagi Y; Aburaya S; Sugiyama N; Narukawa Y; Sakamoto Y; Takahashi M; Uemura H; Yamashita R; Tominaga S; Hayashi S; Nozaki T; Yamada S; Izumi Y; Kashiwagi A; Bamba T; Ishihama Y; Murakami S
Sci Rep; 2021 Sep; 11(1):18398. PubMed ID: 34526589
[TBL] [Abstract][Full Text] [Related]
15. A Uniquely Altered Oral Microbiome Composition Was Observed in Pregnant Rats With
Walkenhorst MS; Reyes L; Perez G; Progulske-Fox A; Brown MB; Phillips PL
Front Cell Infect Microbiol; 2020; 10():92. PubMed ID: 32211345
[No Abstract] [Full Text] [Related]
16. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics insights reveal the remodeling of gut mycobiome with
Chen S; Niu C; Lv W
Front Cell Infect Microbiol; 2022; 12():937725. PubMed ID: 36105149
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
19. The effect of Porphyromonas gingivalis on the gut microbiome of mice in relation to aging.
Giri S; Uehara O; Takada A; Paudel D; Morikawa T; Arakawa T; Nagasawa T; Abiko Y; Furuichi Y
J Periodontal Res; 2022 Dec; 57(6):1256-1266. PubMed ID: 36251393
[TBL] [Abstract][Full Text] [Related]
20. An orally administered oral pathobiont and commensal have comparable and innocuous systemic effects in germ-free mice.
Sato K; Yokoji M; Yamada M; Nakajima T; Yamazaki K
J Periodontal Res; 2018 Dec; 53(6):950-960. PubMed ID: 30047130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
